Profile for European Patent Office Patent: 1453521
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Germany | 122015000093 | ⤷ Start Trial |
| Denmark | CA 2016 00016 | ⤷ Start Trial |
| Luxembourg | 93156 | ⤷ Start Trial |
| Netherlands | 300814 | ⤷ Start Trial |
| Estonia | C20160011 00192 | ⤷ Start Trial |
| Austria | 39/2015 | ⤷ Start Trial |
| France | 15C0050 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1453521
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
